These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26042863)

  • 21. Recent developments in assessing and managing serious health threats.
    Duarte-Davidson R; Griffiths M; Wyke S; Bradley N
    Environ Int; 2014 Nov; 72():1-2. PubMed ID: 24970671
    [No Abstract]   [Full Text] [Related]  

  • 22. Federal funding in support of Ebola medical countermeasures R&D.
    Boddie C
    Health Secur; 2015; 13(1):3-8. PubMed ID: 25812423
    [No Abstract]   [Full Text] [Related]  

  • 23. Point/counterpoint. Preparation for a terrorism-related radiation event should be no different from that for a biological or chemical event.
    Broga DW; Vetter RJ; Orton CG
    Med Phys; 2009 Feb; 36(2):283-5. PubMed ID: 19291967
    [No Abstract]   [Full Text] [Related]  

  • 24. Billions for biodefense: federal agency biodefense budgeting, FY2005-FY2006.
    Schuler A
    Biosecur Bioterror; 2005; 3(2):94-101. PubMed ID: 16000040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. US federal health agencies questioned over Ebola response.
    Jaffe S
    Lancet; 2014 Oct; 384(9953):1489-90. PubMed ID: 25390564
    [No Abstract]   [Full Text] [Related]  

  • 26. Funding agendas: has bioterror defense been over-prioritized?
    May T
    Am J Bioeth; 2005; 5(4):34-44. PubMed ID: 16109694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemical, Biological, Radiological, Nuclear, and Explosive (CBRNE) Science and the CBRNE Science Medical Operations Science Support Expert (CMOSSE).
    Coleman CN; Bader JL; Koerner JF; Hrdina C; Cliffer KD; Hick JL; James JJ; Mansoura MK; Livinski AA; Nystrom SV; DiCarlo-Cohen A; Marinissen MJ; Wathen L; Appler JM; Buddemeier B; Casagrande R; Estes D; Byrne P; Kennedy EM; Jakubowski AA; Case C; Weinstock DM; Dainiak N; Hanfling D; Garrett AL; Grant NN; Dodgen D; Redlener I; MacKAY TF; Treber M; Homer MJ; Taylor TP; Miller A; Korch G; Hatchett R
    Disaster Med Public Health Prep; 2019 Dec; 13(5-6):995-1010. PubMed ID: 31203830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biodefense funding: changes from president's budget to congressional appropriations.
    Sell TK; Gilles K; Franco C
    Biosecur Bioterror; 2012 Sep; 10(3):321-7. PubMed ID: 22897593
    [No Abstract]   [Full Text] [Related]  

  • 29. Biodefense: spend, but spend wisely.
    Green SK; Morin K
    Am J Bioeth; 2005; 5(4):50-2. PubMed ID: 16109698
    [No Abstract]   [Full Text] [Related]  

  • 30. Training security officers to recognize the perils of weapons of mass destruction and pandemic flu contaminates.
    Luizzo AJ; Scaglione BJ
    J Healthc Prot Manage; 2007; 23(2):1-9. PubMed ID: 17907601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Funding and Organization of US Federal Health Security Programs.
    Watson CR; Watson M
    Health Secur; 2017; 15(1):6-7. PubMed ID: 28092455
    [No Abstract]   [Full Text] [Related]  

  • 32. Managing mass casualties and decontamination.
    Chilcott RP
    Environ Int; 2014 Nov; 72():37-45. PubMed ID: 24684820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical care in the "Hot Zone".
    Byers M; Russell M; Lockey DJ
    Emerg Med J; 2008 Feb; 25(2):108-12. PubMed ID: 18212153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances to address European Union Health Security from cross border chemical health threats.
    Duarte-Davidson R; Orford R; Wyke S; Griffiths M; Amlôt R; Chilcott R
    Environ Int; 2014 Nov; 72():3-14. PubMed ID: 24679379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The biases of bioterror funding.
    Schwab A
    Am J Bioeth; 2005; 5(4):54-6. PubMed ID: 16109700
    [No Abstract]   [Full Text] [Related]  

  • 36. Obama calls on Congress to fund $6.2bn emergency Ebola initiative.
    McCarthy M
    BMJ; 2014 Dec; 349():g7503. PubMed ID: 25497740
    [No Abstract]   [Full Text] [Related]  

  • 37. On economic justifications of bioterrorism defense spending.
    Allhoff F
    Am J Bioeth; 2005; 5(4):52-4. PubMed ID: 16109699
    [No Abstract]   [Full Text] [Related]  

  • 38. Confronting terrorism. One year after: hunt for NIH funds fosters collaboration.
    Enserink M
    Science; 2002 Sep; 297(5587):1630-1. PubMed ID: 12215622
    [No Abstract]   [Full Text] [Related]  

  • 39. Implementing the global health security agenda: lessons from global health and security programs.
    Paranjape SM; Franz DR
    Health Secur; 2015; 13(1):9-19. PubMed ID: 25812424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The president's national security agenda: curtailing Ebola, safeguarding the future.
    Gostin LO; Waxman HA; Foege W
    JAMA; 2015 Jan; 313(1):27-8. PubMed ID: 25412348
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.